Dr. Armin Ghobadi, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Lymphoma
Armin Ghobadi, M.D. has run 8 trials for Lymphoma. Some of their research focus areas include:
Acute Myeloid Leukemia
Armin Ghobadi, M.D. has run 8 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Washington University In St. Louis
Clinical Trials Armin Ghobadi, M.D. is currently running
CAR-T Therapy
for Multiple Myeloma
Despite recent therapeutic advances, multiple myeloma (MM) remains an incurable disease. Although survival has improved, there are nevertheless diminishing durations of response to each subsequent line of therapy. This highlights the need for further therapeutic innovation. BCMA-targeting CAR-T cells show impressive response rates; however, their median duration of response is disappointing. The investigators propose that CS1(SLAMF7)-targeting CAR-T cells will fill a gap in the MM armamentarium. CS1 is an attractive target in MM because it is expressed in most patients. Elotuzumab (Empliciti®), an approved anti-CS1 antibody, has proven the clinical efficacy of this target. CAR-T cells are an ideal modality to target CS1, given that two approved treatments, ide-cel (idecabtagene vicleucel, AbecmaTM) and cilta-cel (ciltacabtagene autoleucel, Carvykti™), have proven the potential for cellular immunotherapy in MM. The investigators are testing the safety and preliminary anti-myeloma efficacy of WS-CART-CS1, a CAR-T cell therapy targeting CS1.
Recruiting
1 award
Phase 1
WU-CART-007
for T-Cell Leukemia
The T-RRex study evaluates the efficacy of WU-CART-007 for patients with Relapsed/Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia (T-ALL)/Lymphoblastic Lymphoma (LBL) and to WU-CART-007 as a therapy to induce complete Minimum Residual Disease (MRD) negative response
Recruiting
1 award
Phase 2
6 criteria
More about Armin Ghobadi, M.D.
Clinical Trial Related
4 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Armin Ghobadi, M.D. has experience with
- WU-CART-007
- Mosunetuzumab
- Tabelecleucel
- Cytokine Induced Memory-like NK Cell Adoptive Therapy
- Isatuximab
- Nivolumab
Breakdown of trials Armin Ghobadi, M.D. has run
Lymphoma
Acute Myeloid Leukemia
Multiple Myeloma
Acute Lymphoblastic Leukemia
Cutaneous T-Cell Non-Hodgkin Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Armin Ghobadi, M.D. specialize in?
Armin Ghobadi, M.D. focuses on Lymphoma and Acute Myeloid Leukemia. In particular, much of their work with Lymphoma has involved CD7 positive patients, or patients who are CD20 positive.
Is Armin Ghobadi, M.D. currently recruiting for clinical trials?
Yes, Armin Ghobadi, M.D. is currently recruiting for 6 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Armin Ghobadi, M.D. has studied deeply?
Yes, Armin Ghobadi, M.D. has studied treatments such as WU-CART-007, Mosunetuzumab, Tabelecleucel.
What is the best way to schedule an appointment with Armin Ghobadi, M.D.?
Apply for one of the trials that Armin Ghobadi, M.D. is conducting.
What is the office address of Armin Ghobadi, M.D.?
The office of Armin Ghobadi, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.